Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.
about
A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancerA phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignanciesPhase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancerTailor-made chemotherapy for non-small cell lung cancer patients.E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer.The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religationRole of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.
P2860
Q33344326-6F977458-ED09-4387-8745-1B5F19A80D3FQ33366785-1377B3DE-34E5-48D0-9596-B511784C5497Q33391652-071AB57E-B313-4589-8031-8897114A0DF1Q33400292-F3F1813C-5D36-4F2B-919E-20AEB2993299Q36430761-7B3F21B7-289D-4DD9-AFF7-DBD9655D243CQ36443757-006E967C-4DEA-43AE-B589-148E29323649Q36545904-0B0DC72A-ECD4-49B7-B862-A9CFE326C16DQ42061433-8C2BA025-581A-499D-8FA3-878B1AC2F264
P2860
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Phase II and pharmacokinetic/p ...... ed non-small-cell lung cancer.
@en
type
label
Phase II and pharmacokinetic/p ...... ed non-small-cell lung cancer.
@en
prefLabel
Phase II and pharmacokinetic/p ...... ed non-small-cell lung cancer.
@en
P2093
P356
P1476
Phase II and pharmacokinetic/p ...... ed non-small-cell lung cancer.
@en
P2093
Ingalls ST
P2888
P304
P356
10.1007/S002800000211
P577
2001-01-01T00:00:00Z
P6179
1031170560